tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

RPTX Stock Latest News

Repare Therapeutics Signs Licensing Deal with Debiopharm
Company AnnouncementsRepare Therapeutics Signs Licensing Deal with Debiopharm
17d ago
8K
RPTX
Closing Bell Movers: Victory Capital gains on S&P 400 inclusion
PremiumThe Fly
Closing Bell Movers: Victory Capital gains on S&P 400 inclusion
18d ago
BHF
BLK
Repare Therapeutics enters licensing pact with Debiopharm for Lunresertib
PremiumThe Fly
Repare Therapeutics enters licensing pact with Debiopharm for Lunresertib
18d ago
RPTX
Repare Therapeutics Updates Severance Benefits for Executives
PremiumCompany Announcements
Repare Therapeutics Updates Severance Benefits for Executives
1M ago
8K
RPTX
Repare Therapeutics Holds Annual Shareholder Meeting
PremiumCompany Announcements
Repare Therapeutics Holds Annual Shareholder Meeting
2M ago
8K
RPTX
Repare Therapeutics Strengthens Leadership with New Executive Appointment
PremiumCompany AnnouncementsRepare Therapeutics Strengthens Leadership with New Executive Appointment
2M ago
RPTX
Repare Therapeutics Advances Strategic Partnerships and Clinical Trials Amid Financial Updates
Premium
Company Announcements
Repare Therapeutics Advances Strategic Partnerships and Clinical Trials Amid Financial Updates
3M ago
RPTX
Repare Therapeutics reports Q1 EPS (71c) vs 30c last year
Premium
The Fly
Repare Therapeutics reports Q1 EPS (71c) vs 30c last year
3M ago
RPTX
Repare Therapeutics expects cash to fund operations through 2027
PremiumThe Fly
Repare Therapeutics expects cash to fund operations through 2027
3M ago
RPTX
RPTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
RPTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
RPTX
Repare Therapeutics Out-Licenses Platforms to DCx Biotherapeutics
PremiumCompany Announcements
Repare Therapeutics Out-Licenses Platforms to DCx Biotherapeutics
3M ago
8K
RPTX
Cathie Wood Snags Robinhood Stock (HOOD) and GitLab (GTLB) as Markets Slide
PremiumMarket News
Cathie Wood Snags Robinhood Stock (HOOD) and GitLab (GTLB) as Markets Slide
4M ago
GTLB
HOOD
Repare Therapeutics Announces Leadership Changes in 2025
PremiumCompany AnnouncementsRepare Therapeutics Announces Leadership Changes in 2025
4M ago
8K
RPTX
Repare Therapeutics CEO Lloyd Segal resigns, Steve Forte succeeds
Premium
The Fly
Repare Therapeutics CEO Lloyd Segal resigns, Steve Forte succeeds
4M ago
RPTX
Cathie Wood’s ARK Invest Snaps Up Tesla Stock (TSLA) amid 42% Price Drop
Premium
Market News
Cathie Wood’s ARK Invest Snaps Up Tesla Stock (TSLA) amid 42% Price Drop
4M ago
AMGN
ARKK
Repare Therapeutics: Strategic Focus and Financial Stability Underpin Buy Rating
PremiumRatings
Repare Therapeutics: Strategic Focus and Financial Stability Underpin Buy Rating
5M ago
RPTX
Strategic Pipeline Focus and Financial Stability Support Buy Rating for Repare Therapeutics
PremiumRatings
Strategic Pipeline Focus and Financial Stability Support Buy Rating for Repare Therapeutics
5M ago
RPTX
Repare Therapeutics price target lowered to $5 from $10 at H.C. Wainwright
PremiumThe Fly
Repare Therapeutics price target lowered to $5 from $10 at H.C. Wainwright
5M ago
RPTX
Repare Therapeutics Focuses on Clinical Trials Amid Restructuring
PremiumCompany Announcements
Repare Therapeutics Focuses on Clinical Trials Amid Restructuring
5M ago
RPTX
Repare Therapeutics Restructures and Focuses on Key Clinical Trials
PremiumCompany AnnouncementsRepare Therapeutics Restructures and Focuses on Key Clinical Trials
5M ago
RPTX
Repare Therapeutics reports Q4 EPS (67c), consensus (79c)
Premium
The Fly
Repare Therapeutics reports Q4 EPS (67c), consensus (79c)
5M ago
RPTX
RPTX Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
RPTX Upcoming Earnings Report: What to Expect?
5M ago
RPTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >